Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of a Method for Analysis of Alzheimer´s Disease Specific Proteins in Nasal Secretion

NCT05791552 is registered in ClinicalTrials.gov with Noselab GmbH as lead sponsor.

NCT NCT05791552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05791552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of a Method for Analysis of Alzheimer´s Disease Specific Proteins in Nasal Secretion
Lead sponsor
Noselab GmbH
Phase
Not applicable
Overall status
Unknown status
Start date
February 15, 2022
Completion date
September 1, 2023
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, brain nose interface, nasal secretion